Centers for Disease Control and Prevention (CDC). Updated Report (VAERS)

Updated: Jul 28, 2021

25 May 2021 Michael Moore | Email:

Please support us by sharing and subscribing; Help us get the truth out there.

Follow us on Telegram

VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.

VEARS has issued an updated report on the adverse reactions to the latest mNRA Vaccines or GMO Therapy for humans. This report shows that between Dec. 14, 2020 and April 30, there was a total of 157,277 total adverse events reported to VAERS, including 3,837 deaths — an increase of 293 over the previous week — and a total of 16,014 serious injuries, up 2,467 since last week.

The number of deaths by ‘vaccination’ is increasing weekly according to Governmental figures.

According to official figures, 240.2 million COVID vaccine doses have been administered as of April 30. This includes 105 million doses of Moderna, 127 million doses of Pfizer and 8 million doses of the Johnson &Johnson (J&J) COVID vaccine.

Of the 3,837 deaths reported as of April 30, a quarter occurred within 48 hours of vaccination, 16 percent within 24 hours and 39percent in people who became ill within 48 hours of receiving the vaccination.

Further, according to the CDC figures, This week’s VAERS data shows:

Despite the above figures, the FDA (Federal Drug Administration) is set to authorize (or authorized) Pfizer vaccine for young teens aged 12 to fifteen by early next week.

On May 4, The Defender reported the U.S. Food and Drug Administration (FDA) is preparing to authorize use of the Pfizer-BioNTech COVID vaccine in adolescents 12 to 15 years old by early next week and Pfizer is going to ask for the expanded Use Authorization so that children as young as 2 can be forcibly vaccinated.

‘According to CDC data, the death rate among adolescents ages 0 to 17 who get COVID and are subsequently hospitalized is 0.7%, with many experiencing either mild or no symptoms at all. The COVID death rate in all adolescent age categories is less than 0.1%, leading some experts to question whether vaccines should be targeted to an age group that so far appears to be mostly spared from severe COVID.

Just recently a third U.S. male was diagnosed with vaccine-induced blood clots and a woman died from brain hemorrhage after receiving the J&J (Johnson & Johnson) vaccine.

The Defender, a Children’s Health Defense News service May 6, on May 6th reported ‘doctors at University of Utah Health treated the third male to develop vaccine-induced thrombotic thrombocytopenia in the U.S.’

‘The man, under age 50, received J&J’s vaccine in early April. Ten days later he experienced pain in his toes, which then progressed to his thighs. He later began experiencing chest pain. A CT scan revealed a bilateral pulmonary embolism. Physicians discovered low platelets and blood clots in his legs and lungs, leading them to suspect VITT was the cause.’

On May 4, They also reported a 35-year-old Michigan woman dying from complications 11 days after receiving the J&J’s vaccine. The woman’s family said her headache started on April 16, eight days after being vaccinated. She died three days later. Her death certificate notes a natural death, specifically from an acute subarachnoid hemorrhage, or bleeding between the brain and tissue around the brain.

The attending physician filed a report to VAERS. In an email to the family, the CDC confirmed her death had been reported to VAERS, but said the system is not designed to determine whether a reported adverse event was caused by the vaccine.’

‘Of the 2,808 cases reported, there were 1043 reports attributed to Pfizer, 893 reports to Moderna and 860 reports to J&J — 847 cases more than U.S. health officials acknowledged during the April 23 meeting where it was recommended the pause be lifted on J&J’s vaccine.

Other countries have rejected some of the vaccines including Denmark rejecting the J&J Vaccine.

The Danish Health Authority said in a statement “….it had concluded the benefits of using the COVID-19 vaccine from J&J do not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.”

“Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from COVID-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate,” the health authority said.

The previous month they had halted use of the AstraZeneca vaccine due to the increased risk of blot clots. Other European countries are following suit.

The Defender has made repeated attempts to contact CDC with questions as, according to their website (CDC) all deaths are followed up. Yet to date there has been a deathly silence.

115 views0 comments

Recent Posts

See All